MEMBER HIGHLIGHT
ENDOVAC Animal Health, a subsidiary of IMMVAC, Inc., was founded in 1983 on a proprietary technology called ENDOVAC® for gram-negative bacteria such as E. coli, Salmonella, Pasteurella and Mannheimia that contains a unique E3 immune stimulant. The science surrounding development of ENDOVAC was focused on providing solutions to some of the most prominent health issues impacting production livestock.
Today, ENDOVAC-Dairy® is a leading prevention tool for mastitis in dairy cattle. ENDOVAC-Beef® is continuing to grow in use in all segments of the beef industry as a powerful tool to aid in prevention of multiple gram-negative diseases. In recent years, ENDOVAC-Porci® has made its mark in swine health in aiding in prevention of various gram-negative diseases.
ENDOVAC Animal Health’s headquarters are located in Columbia with both domestic and international sales. The team is excited to be unveiling a new 23,000 square foot BSL II vaccine production facility in August. This facility will allow for added growth in production of the flagship product portfolio, additional room for research and development and future production of other product lines.
ENDOVAC Animal Health is a proactive organization providing animal health products with the highest integrity for our customers and employees.
Read more about: ENDOVAC Animal Health
